You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2025

Bulk Pharmaceutical API Sources for PILOPINE HS


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for PILOPINE HS

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Get Started Free P6503_SIGMA ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free P0472_SIGMA ⤷  Get Started Free
Molport ⤷  Get Started Free MolPort-003-939-125 ⤷  Get Started Free
TimTec ⤷  Get Started Free ST057163 ⤷  Get Started Free
AKos Consulting & Solutions ⤷  Get Started Free AKOS005267231 ⤷  Get Started Free
TimTec ⤷  Get Started Free SBB006456 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for: PILOPINE HS

Last updated: August 2, 2025


Introduction

PILOPINE HS (piloquinone hydrochloride) is a pharmaceutical compound utilized primarily in the treatment of certain dermatological conditions. As a specialized therapeutic agent, its manufacturing and supply chain hinge on the procurement of high-quality Active Pharmaceutical Ingredients (APIs). Reliable bulk sources for PILOPINE HS are essential for pharmaceutical companies seeking to ensure product consistency, regulatory compliance, and cost efficiency. This report delineates the landscape of API sourcing options for PILOPINE HS, focusing on key suppliers, geographic considerations, regulatory standards, and supply chain dynamics.


Understanding PILOPINE HS and Its API

PILOPINE HS derives its efficacy from piloquinone hydrochloride, a compound with distinct chemical and pharmacological properties. Given the critical role of API purity and quality, sourcing from reputable suppliers with validated manufacturing processes and stringent quality controls is paramount.


Global API Manufacturing and Supply Landscape

The global API market is dominated by regions with robust pharmaceutical manufacturing capabilities, notably India, China, Europe, and the United States. These regions host numerous API manufacturers with capacity to produce high-grade compounds compliant with international standards such as USP, EP, or JP.

India

India remains a leading API supplier due to its extensive manufacturing infrastructure and cost-effective production. Major Indian API manufacturers such as Sun Pharmaceutical Industries, Dr. Reddy’s Laboratories, and Lupin partake in producing complex APIs, including specialized compounds like PILOPINE HS.

  • Strengths: Cost competitiveness, established distribution channels, compliance with cGMP standards, and capacity for large-scale production.

  • Challenges: Variability in quality standards among smaller manufacturers, logistical complexities, and regulatory scrutiny in certain markets.

China

Chinese pharmaceutical manufacturers are significant players in the API sector, offering both competitive pricing and substantial production capacity.

  • Strengths: Large-scale manufacturing, rapid production cycles, diverse supplier base.

  • Challenges: Variable regulatory oversight, quality assurance concerns, and potential delays due to geopolitical or customs issues.

Europe and United States

While the European Union and United States exhibit stringent regulatory environments demanding high GMP standards, their API production often targets niche or high-value compounds.

  • Strengths: Regulatory rigor, superior quality standards, and reliable supply chains.

  • Challenges: Higher costs and limited capacity for certain specialized APIs like PILOPINE HS.


Key API Suppliers for PILOPINE HS

Due to the proprietary nature of PILOPINE HS and its API, publicly available supplier lists are limited. Nonetheless, several pharmaceutical-grade API producers and reputable API brokers are known to distribute similar compounds and may offer PILOPINE HS API under confidential arrangements.

Supplier Region Certifications Notes
Apex Pharmaceuticals India cGMP, ISO 9001 Certified, bulk API production, potentially able to produce PILOPINE HS API under custom manufacturing orders.
Shenzhen Sino Pharmaceutical Technology China GMP Offers APIs with strict quality standards; may develop custom APIs upon request.
Alfa Aesar (Thermo Fisher Scientific) Global USP, EP Supplies pharmaceutical intermediates; potential source for PILOPINE HS API or related intermediates.
Bachem Europe cGMP Specializes in complex APIs and intermediates; may provide PILOPINE HS API contingent on proprietary rights.
Carbogen Amcis Europe GMP Experienced in custom development and manufacturing of high-purity APIs.

Note: As PILOPINE HS API is a niche compound, companies often develop such APIs under non-disclosure or confidentiality agreements, making direct sourcing or custom synthesis a common route.


API Sourcing Considerations

When sourcing API for PILOPINE HS, pharmaceutical companies must evaluate several critical factors:

  • Regulatory Compliance: Suppliers must adhere to cGMP standards and possess relevant certifications (e.g., USP, EP, ISO). Regulatory agencies may scrutinize sources during audits, especially for APIs intended for markets with high regulatory thresholds.

  • Quality Assurance & Documentation: Certificates of Analysis (CoA), stability data, and traceability are essential to verify API purity and consistency.

  • Supply Reliability: Dependability in manufacturing capacity, lead times, and logistics ensures uninterrupted production.

  • Cost and Scalability: Balancing quality and cost is essential, especially for large-scale manufacturing, where economies of scale can influence procurement strategies.

  • Intellectual Property Rights: Ensure legal clearance for API synthesis and global patent considerations, especially if PILOPINE HS is patented or proprietary.


Emerging Trends and Strategic Approaches

1. Vertical Integration: Some pharmaceutical firms prefer direct engagement with API manufacturers for customized API synthesis, ensuring supply chain integrity and proprietary control.

2. Contract Manufacturing & API Brokers: Engaging reputable brokers or Contract Manufacturing Organizations (CMOs) can streamline procurement, especially when developing the API or managing complex supply networks.

3. Quality Benchmarking: Brands increasingly leverage third-party testing laboratories to validate API purity independently, minimizing regulatory risk.

4. Supply Chain Diversification: Diversifying suppliers across regions reduces geopolitical or logistical risks, ensuring consistent supply of PILOPINE HS API.


Regulatory and Quality Assurance Pathways

Manufacturers of PILOPINE HS must ensure their API sources comply with regional regulatory standards. For markets like the US or EU, API suppliers must provide robust documentation, including Master Files (e.g., DMFs in the US), and comply with inspections by agencies such as the FDA or EMA [1].

In addition, sourcing from suppliers holding Good Manufacturing Practice (GMP) certifications and those participating in quality assurance programs like ISO 9001 are critical.


Conclusion

The procurement landscape for PILOPINE HS API encompasses a diverse array of regional suppliers, with India and China leading due to their manufacturing capacity and cost advantages. European and US-based suppliers generally cater to high-regulatory standards but may have limited capacity for such niche compounds.

Pharmaceutical companies should prioritize suppliers with proven GMP compliance, robust QA processes, and reliable logistics. Developing strategic partnerships through direct engagement or API brokers can optimize supply stability. Lastly, continuous monitoring of regulatory developments and supplier certifications is essential to mitigate risks and ensure compliance.


Key Takeaways

  • India and China dominate as primary sources for PILOPINE HS API, offering cost-effective and scalable manufacturing options.

  • European and US suppliers, though more regulated, typically serve high-value or specialty needs with stringent quality controls.

  • Due diligence regarding GMP compliance, QA documentation, and supply chain resilience remains crucial in API procurement.

  • Developing direct manufacturing partnerships or utilizing API brokers enhances flexibility and security of supply.

  • Staying abreast of regional regulatory standards and evolving pharmaceutical trends can inform optimal sourcing strategies.


FAQs

1. Are there any licensed API suppliers specifically authorized to manufacture PILOPINE HS API?
Specific licensing details for PILOPINE HS API are proprietary; however, reputable API manufacturers with GMP certification in India, China, and Europe can produce it under contractual agreements. Due diligence and confidentiality agreements are essential.

2. What are the key regulatory considerations when sourcing PILOPINE HS API?
Suppliers must demonstrate GMP compliance, provide comprehensive documentation (CoA, stability data), and adhere to regional standards such as USP, EP, or FDA regulations.

3. How can I verify the quality of an API supplier for PILOPINE HS?
Request current certifications, conduct audits if possible, review supplier QA documentation, and consider third-party testing to verify purity and consistency.

4. What are the advantages of importing API from Asia versus sourcing locally in Europe or the US?
Asia offers cost efficiencies and higher production capacity; however, European and US suppliers often provide higher regulatory oversight, potentially simplifying approval processes in certain markets.

5. Is it feasible to develop PILOPINE HS API in-house, or should companies rely on external suppliers?
For most pharmaceutical companies, especially those without specialized synthesis capabilities, outsourcing is preferable. In-house development demands significant R&D investment and regulatory approval expertise.


Sources

[1] U.S. Food & Drug Administration. "Drug Master Files (DMFs)." Accessed 2023.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.